Takeda invests in continuous processing; Actavis recalls metformin;

> Takeda Ventures is investing €3 million ($3.3 million) in Belgium-based Univercells and will tailor Univercells' continuous integrated manufacturing methods for Takeda's vaccines production processes. Release

> India's National Dairy Development Board has started manufacturing from a new $38.6 million animal and human vaccine manufacturing plant near Hyderabad. Story

> Pharmaceutical production increased 29.2% in Singapore for the 12 months ending Sept. 30, coming off a low base the year before. Story

> Actavis is recalling more than 13,280 bottles of metformin after a lot failed dissolution testing. Recall

> Canada's Apotex is recalling 28,802 bottles of Bromfenac Ophthalmic Solution after lots failed preservative effectiveness testing. Recall